Thinly traded nano cap Titan Pharmaceuticals (NASDAQ:TTNP) is up 12% premarket on light volume in reaction to its agreement with CVS Health unit CVS Caremark for the distribution of its Probuphine (buprenorphine) implant for the treatment of opioid use disorder.
Financial terms are not disclosed.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.